Skip to content

Crossroads Neurovascular, Inc.

Also registered as CROSSROADS NEUROVASCULAR

United StatesFDA 510(k) applicant, unverified

Devices
2

What Crossroads Neurovascular, Inc. makes

Crossroads Neurovascular, Inc. manufactures the PATH BGC, a neurovascular device designed for intracranial aneurysm treatment. The device is intended for embolization procedures to occlude blood flow within aneurysms, reducing the risk of rupture.

The PATH BGC is classified as a Class II medical device under FDA regulations and is listed via the 510(k) clearance process. The company is based in the United States.

AI-generated from registry data, 3 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue2

Newest first, rows 1-2 of 2

  • Path Bgc Ref K242392

    Class II
    Active 510(k) 510(k) II

  • Path Bgc Ref K260938

    Class II
    Active 510(k) 510(k) II

Frequently asked questions

How many devices does Crossroads Neurovascular, Inc. have in the registry?

The registry currently lists 2 devices for Crossroads Neurovascular, Inc.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Crossroads Neurovascular, Inc.'s devices?

Among its 2 most recently registered devices, Crossroads Neurovascular, Inc. has devices listed in FDA 510(k) (2 devices).

What risk classes do Crossroads Neurovascular, Inc.'s devices fall under?

Among its 2 most recently registered devices, the classes recorded for Crossroads Neurovascular, Inc.'s devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Crossroads Neurovascular, Inc. in the registry?

The most recently registered devices listed for Crossroads Neurovascular, Inc. include PATH BGC.

Generated automatically from registry data and not verified by a human reviewer.